0001479290-18-000095.txt : 20180706
0001479290-18-000095.hdr.sgml : 20180706
20180706211715
ACCESSION NUMBER: 0001479290-18-000095
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180706
FILED AS OF DATE: 20180706
DATE AS OF CHANGE: 20180706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Allouche Cyril
CENTRAL INDEX KEY: 0001744573
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 18943233
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-742-3400
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
wf-form4_153092621726058.xml
FORM 4
X0306
4
2018-07-06
0
0001479290
Revance Therapeutics, Inc.
RVNC
0001744573
Allouche Cyril
C/O REVANCE THERAPEUTICS, INC
7555 GATEWAY BLVD
NEWARK
CA
94560
0
1
0
0
Principal Financial Officer
Common Stock
2018-07-06
4
S
0
393
28.35
D
4750
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Allouche.
/s/ Gordon Ho, Attorney-in-Fact
2018-07-06